NCT00094861View on ClinicalTrials.gov

Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

January 31, 2014

Conditions
DysphagiaNon-Small Cell Lung CancerLung Cancer
Interventions
DRUG

Palifermin

DRUG

Placebo

RADIATION

Radiotherapy

DRUG

Paclitaxel

DRUG

Carboplatin

Sponsors

Collaborators (1)

Amgen
All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

Swedish Orphan Biovitrum

INDUSTRY

NCT00094861 - Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC) | Biotech Hunter | Biotech Hunter